Literature DB >> 7942939

Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension.

B P Grubb1, D Samoil, D Kosinski, D Wolfe, M Lorton, E Madu.   

Abstract

OBJECTIVE: To evaluate the usefulness of fluoxetine hydrochloride in the treatment of patients with severe refractory orthostatic hypotension.
DESIGN: Prospective, nonrandomized study. PATIENTS: Five patients (3 men, 2 women with a mean age of 67 +/- 7 years with chronic symptomatic orthostatic hypotension resistant to or intolerant of other therapies.
METHODS: Symptoms and orthostatic responses were recorded in the baseline state. Fluoxetine hydrochloride 20 mg orally once daily was started and patients were reevaluated after 6 to 8 weeks of therapy.
RESULTS: All patients demonstrated orthostatic hypotension (20 mm Hg or greater decline in systolic blood pressure) associated with symptoms (eg, dizziness, vertigo, near syncope) in the baseline state. After 6 to 8 weeks of fluoxetine therapy, 2 patients reported resolution of all symptoms, 2 had a marked reduction in symptoms, and 1 patient experienced no effect. Orthostatic responses were attenuated in 4 of the 5 patients (80%).
CONCLUSION: Fluoxetine hydrochloride may be an effective therapy for some patients with recurrent severe orthostatic hypotension refractory to other forms of therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942939     DOI: 10.1016/0002-9343(94)90304-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

Review 1.  The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances.

Authors:  B P Grubb; B J Karas
Journal:  J Interv Card Electrophysiol       Date:  1998-12       Impact factor: 1.900

Review 2.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

3.  Sibutramine and the sympathetic nervous system in obese humans.

Authors:  William G Haynes; Zoltan Egri
Journal:  Clin Auton Res       Date:  2005-06       Impact factor: 4.435

Review 4.  Diagnosis and management of patients with blackouts.

Authors:  Adam P Fitzpatrick; Paul Cooper
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

Review 5.  Management of postural hypotension.

Authors:  M S Kochar
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

6.  Fludrocortisone in the treatment of hypotensive disorders in the elderly.

Authors:  R M Hussain; S J McIntosh; J Lawson; R A Kenny
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

Review 7.  5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.

Authors:  Stephanie W Watts; Robert Patrick Davis
Journal:  Cardiovasc Ther       Date:  2011-02       Impact factor: 3.023

Review 8.  Neurologic complications of diabetes.

Authors:  Gerald A Charnogursky; Nicholas V Emanuele; Mary Ann Emanuele
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

9.  Current Management of Syncope: Treatment Alternatives.

Authors:  Carlos A. Morillo; Adrián Baranchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

10.  Postpartum postural orthostatic tachycardia syndrome in a patient with the joint hypermobility syndrome.

Authors:  Khalil Kanjwal; Beverly Karabin; Yousuf Kanjwal; Blair P Grubb
Journal:  Cardiol Res Pract       Date:  2009-10-11       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.